We collaborate with leading medical universities and hospitals to uncover how compounds from our bioprocessed marine ingredients can become the medicine of tomorrow.
HBC signed a second research agreement with Stanford University 6 May 2020. The agreement is a continuation of an established research collaboration that has shown promising results. The research program will further investigate the GI-protective properties of SPH / ProGo® in children and adults with GI tract disorders.
Studies show that salmon oil proteins from Hofseth Biocare can work well for asthma patients. The company is now embarking on a fast track study to document the effect the oil can also help save lives among COVID-19 patients with difficulty breathing.
Why Hofseth Biocare’s unique approach to pharmaceutical research transcends conventional methods
Why Hofseth Biocare is the only company reaping the benefits of a leading-edge process for producing high-end health products